Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind Study to Evaluate the Safety and Effectiveness of the Exhale® Drug-Eluting Stent in Homogeneous Emphysema Subjects With Severe Hyperinflation

NCT00391612 is registered in ClinicalTrials.gov with Broncus Technologies as lead sponsor.

NCT NCT00391612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00391612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind Study to Evaluate the Safety and Effectiveness of the Exhale® Drug-Eluting Stent in Homogeneous Emphysema Subjects With Severe Hyperinflation
Lead sponsor
Broncus Technologies
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2006
Completion date
December 31, 2013
Enrollment
450 (estimated)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

emphysema